Funding for the Centre for Commercialization of Cancer Immunotherapy

In 5 seconds

The $ 15-million grant to the Centre for Commercialization of Cancer Immunotherapy (C3i) will go towards the development, application and commercialization of cancer immunotherapy.

“We’ve just taken another step in the fight against cancer.” These are the words that Mr. Yvan Gendron, President and CEO of the Centre intégré universitaire de santé et de services sociaux de l’Est-de-l’Île-de-Montréal, expressed during a celebration of a major project that demonstrates the excellence in cancer research at Hôpital Maisonneuve-Rosemont (HMR).

Read the press realease (.pdf version)